Biotin in the US continued a measured uptrend into early February as balanced market conditions and steady end-user demand underpinned offers. Early January saw incremental upside that extended through the month, with late-January trading characterized by disciplined supplier behavior and consistent buying from nutraceutical and supplement formulators. Participants reported no meaningful supply disruptions, and sellers avoided aggressive discounting, enabling the market to consolidate gains. The tone remained constructive rather than volatile, with momentum driven by steady commercial demand rather than speculative activity. The nutraceuticals and dietary supplement sector remained the core support, with formulators continuing to procure biotin for finished products. The sector stayed robust, with no prominent weak end-use segments pulling prices lower. Upstream costs remained broadly unchanged, contributing to stable margins and modest price gains. Producers and distributors maintained firm offers, reflecting supply-side discipline and stable inventories. Looking ahead, the near-term outlook calls for stability with a gradual upside, supported by steady demand and balanced supply.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
